Thema: INE044A01036
Sun Pharma, INE044A01036
stock-1863880_1920.jpg - Foto: THN
Sun Pharma stock: Nomura cuts target to Rs 2,260
Nomura kept its Buy rating but lowered its target after slower specialty growth. Sun Pharma stock retains support from strong Indian demand and the Organon deal.
ad-hoc-news.de, heute 03:24 Uhr
Sun Pharma, INE044A01036
Sun Pharma reports UNLOXCYT designation: October 30 results ...
UNLOXCYT received Category 2A status on October 20, 2026. Sun Pharma stock faces INR 158.25 billion revenue estimates for October 30.
ad-hoc-news.de, 22.10.26 09:59 Uhr
Sun Pharma, INE044A01036
Sun Pharma stock: Results are due November 3 2026 for Sun ...
Geojit target stands at INR 2,070. Sun Pharma stock was INR 1,745.10 on NSE, up 0.12 percent from INR 1,743.00 on October 21, 2026.
ad-hoc-news.de, 21.10.26 17:44 Uhr
Sun Pharma, INE044A01036
Sun Pharma stock: Sun Pharma schedules October 30 results ...
Q1 fiscal 2027 revenue rose 10.50 percent. Sun Pharma stock costs INR 1,743.00 on October 19, 2026, down 0.90 percent versus its prior close.
ad-hoc-news.de, 20.10.26 16:48 Uhr
Sun Pharma, INE044A01036
Sun Pharma approves INR 100.0 billion plan. Sun Pharma stock ...
First-quarter fiscal 2027 revenue reached INR 153.0 billion, while operating margin was 29.00 percent. Sun Pharma stock has INR 4.2 trillion market value.
ad-hoc-news.de, 20.10.26 10:17 Uhr
Sun Pharma, INE044A01036
Sun Pharma stock: Informist cites INR 2,148 average target ...
Results are due October 30, 2026. Sun Pharma stock costs INR 1,743.00 on October 19, 2026, down 0.90 percent versus the NSE close.
ad-hoc-news.de, 19.10.26 17:03 Uhr
Sun Pharma, INE044A01036
Sun Pharma sets October 30 results: 27 of 31 rate Sun Pharma ...
Q1 fiscal 2027 revenue reached INR 153.0 billion, up 10.5 percent year on year. Sun Pharma stock costs INR 1,742.70 at NSE on October 19, 2026 after INR 1,758.80.
ad-hoc-news.de, 19.10.26 09:51 Uhr
Sun Pharma, INE044A01036
Sun Pharma stock: Results are due October 29 for Sun Pharma ...
Sun Pharma's trailing P/E was 34.89 on October 16, 2026. Sun Pharma stock costs INR 1,758.80 on October 16, 2026, down 0.29 percent on NSE.
ad-hoc-news.de, 16.10.26 17:05 Uhr
Sun Pharma, INE044A01036
Crisil rates Sun Pharma debt AAA. Sun Pharma stock is valued ...
The board approved an INR 100.0 billion debt plan on October 12, 2026. Sun Pharma stock saw Q1 fiscal 2027 revenue reach INR 153.00 billion.
ad-hoc-news.de, 16.10.26 11:11 Uhr
Sun Pharma, INE044A01036
Analyst consensus puts Sun Pharma stock at INR 2,180.00
